Although reports have been conflicting [21], [35], [36], decrease or loss of p16 and p27 expression can be a predictor of poor prognosis [20], [37], whereas p53 overexpression appears to correlate with increased malignant risk in GIST in some studies [28], [38]. The gene discussed is TP53; the disease is gastrointestinal stromal tumor.